Skip to main content
SpringerLink
Log in

Clinical Trials Report

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Corti R, Burnett JC, Rouleau JL, et al.: Vasopeptidase inhibitors — a new therapeutic concept in cardiovascular disease? Circulation 2001, 104:1856–1862.

    PubMed  CAS  Google Scholar 

  2. Rouleau JL, Pfeffer MA, Stewart DJ, et al.: Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet 2000, 356:615–620.

    Article  PubMed  CAS  Google Scholar 

  3. Gibbs CR, Lip GY, Beevers DG: Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br J Clin Pharmacol 1999, 48:861–865.

    Article  PubMed  CAS  Google Scholar 

  4. Messerli FH, Nussberger J: Vasopeptidase inhibition and angio-oedema. Lancet 2000, 356:608–609.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Frank T. Ruschitzka MD, FESC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruschitzka, F.T. Clinical Trials Report. Current Science Inc 5, 57–58 (2003). https://doi.org/10.1007/s11906-003-0011-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-003-0011-3

Keywords

Search

Navigation